Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00592462 · ClinicalTrials.gov registry record
Whole Body Magnetic Resonance Imaging (MRI) for Detection of Cancer Metastases
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 32
- Enrollment target
NCT00592462: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00592462 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00592462 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
The objective of this pilot study is to develop and evaluate a whole body MRI technique for detecting cancer metastases. The whole body MRI will include T1-weighted and T2-weighted phase-sensitive MR imaging as well as diffusion weighted imaging of the whole body in multiple patient table stations.
Interventions
- PROCEDURE Whole Body MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2007-12 |
| Est. Completion | 2015-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00592462
The ClinicalTrials.gov registry entry for NCT00592462 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Whole Body MRI is the first listed.
NCT00592462 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00592462 about?
NCT00592462 is a clinical study titled "Whole Body Magnetic Resonance Imaging (MRI) for Detection of Cancer Metastases". The objective of this pilot study is to develop and evaluate a whole body MRI technique for detecting cancer metastases. The whole body MRI will include T1-weighted and T2-weighted phase-sensitive MR imaging as well as diffusion weighted imaging of the whole body in multiple patient table stations.
What is the current status of trial NCT00592462?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2007-12. Estimated completion is 2015-12.
What interventions are being tested in trial NCT00592462?
The interventions under investigation include: Whole Body MRI (PROCEDURE).
Who is sponsoring clinical trial NCT00592462?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.